MUDr. Ján Podhorec
Assistant professor, Comprehensive Cancer Care Department
Total number of publications: 37
2022
-
Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory
Year: 2022, type: Conference abstract
-
Proteotype classification of renal cell carcinoma for prognosis and therapy response
Year: 2022, type: Conference abstract
2021
-
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Year: 2021, type: Conference abstract
-
DIA-MS Identifies and Validates Transgelin as Protein Contributing to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
Year: 2021, type: Conference abstract
-
Proteotypová analýza renálního karcinomu ve vztahu k prognóze a terapeutické odpovědi
Year: 2021, type: Appeared in Conference without Proceedings
-
SWATH-MS identifikácia stathminu ako potenciálneho markeru nádorov endometria u pacientok liečených tamoxifenom analýzou FFPE tkanív
Year: 2021, type: Conference abstract
-
Transgelin Contributes to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment
Biomedicines, year: 2021, volume: 9, edition: 9, DOI
2020
-
Transgelin contributes to a poor response of metastatic renal cell carcinoma to sunitinib treatment
Year: 2020, type: Conference abstract
-
Transgelin negativně přispívá k léčebné odpovědi pacientů s metastatickým reálním karcinomem léčených tyrosinkinasovými inhibitory
Year: 2020, type: Conference abstract
2019
-
AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy
Oncology letters, year: 2019, volume: 18, edition: 5, DOI